ArticleCell death & disease2022

CircLIFR suppresses hepatocellular carcinoma progression by sponging miR-624-5p and inactivating the GSK-3β/β-catenin signaling pathway.

Lei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.